Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru Medical Dialogues Bureau23 Sept 2019 10:15 AM IST"At the conclusion of the inspection, we received a Form 483 with four observations for the new Drug Substance facility, three observations for the...
Biocon inks license, supply pact with CMS for 3 generic formulations Medical Dialogues Bureau13 Sept 2019 2:45 PM ISTUnder the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs Medical Dialogues Bureau15 Aug 2019 9:30 AM ISTThe combined synergies of Narayana Health as a knowledge partner, Syngene and Biocon Foundation as funding partners and Agastya International as the...
Biocon appoints Mayank Verma as Company Secretary, Compliance Officer Farhat Nasim27 July 2019 9:00 AM ISTPrior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow Medical Dialogues Bureau13 July 2019 12:55 PM ISTA further donation of USD 2.5 million will go towards creating a new Professorial Chair to be named the Mazumdar-Shaw Chair of Precision Oncology....
Biocon commercial rights on biosimilar adalimumab extends to global markets Farhat Nasim8 May 2019 9:45 AM ISTBiocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
Launching product without Approval: DOP rejects Biocon Plea against NPPA action Meghna A Singhania24 Feb 2019 11:25 AM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
